These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21722763)

  • 21. Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation.
    Snykers S; Henkens T; De Rop E; Vinken M; Fraczek J; De Kock J; De Prins E; Geerts A; Rogiers V; Vanhaecke T
    J Hepatol; 2009 Jul; 51(1):187-211. PubMed ID: 19457566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic modification-free reprogramming to induced pluripotent cells: fantasy or reality?
    Tada T
    Cell Stem Cell; 2008 Aug; 3(2):121-2. PubMed ID: 18682230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reprogramming language of pluripotency.
    Welstead GG; Schorderet P; Boyer LA
    Curr Opin Genet Dev; 2008 Apr; 18(2):123-9. PubMed ID: 18356040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards an understanding of the regulatory mechanisms of totipotency.
    Ishiuchi T; Torres-Padilla ME
    Curr Opin Genet Dev; 2013 Oct; 23(5):512-8. PubMed ID: 23942314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation of reprogramming factors towards pluripotency in mouse preimplantation development.
    Miyanari Y; Torres-Padilla ME
    Curr Opin Endocrinol Diabetes Obes; 2010 Dec; 17(6):500-6. PubMed ID: 20962633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming of somatic cell identity.
    Hanna J; Carey BW; Jaenisch R
    Cold Spring Harb Symp Quant Biol; 2008; 73():147-55. PubMed ID: 19022760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germ cell specification in mice: signaling, transcription regulation, and epigenetic consequences.
    Saitou M; Yamaji M
    Reproduction; 2010 Jun; 139(6):931-42. PubMed ID: 20371640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear reprogramming and pluripotency of embryonic cells: Application to the isolation of embryonic stem cells in farm animals.
    Renard JP; Maruotti J; Jouneau A; Vignon X
    Theriogenology; 2007 Sep; 68 Suppl 1():S196-205. PubMed ID: 17610945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells.
    Liu N; Lu M; Tian X; Han Z
    J Cell Physiol; 2007 May; 211(2):279-86. PubMed ID: 17195167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concise Review: Energy Metabolites: Key Mediators of the Epigenetic State of Pluripotency.
    Moussaieff A; Kogan NM; Aberdam D
    Stem Cells; 2015 Aug; 33(8):2374-80. PubMed ID: 25873344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pluripotency and Epigenetic Factors in Mouse Embryonic Stem Cell Fate Regulation.
    Morey L; Santanach A; Di Croce L
    Mol Cell Biol; 2015 Aug; 35(16):2716-28. PubMed ID: 26031336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes.
    Santourlidis S; Wernet P; Ghanjati F; Graffmann N; Springer J; Kriegs C; Zhao X; Brands J; Araúzo-Bravo MJ; Neves R; Koegler G; Uhrberg M
    Stem Cell Res; 2011 Jan; 6(1):60-9. PubMed ID: 20933485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oct4 interaction with Hmgb2 regulates Akt signaling and pluripotency.
    Campbell PA; Rudnicki MA
    Stem Cells; 2013 Jun; 31(6):1107-20. PubMed ID: 23495099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reprogramming cell fates: insights from combinatorial approaches.
    Pereira CF; Lemischka IR; Moore K
    Ann N Y Acad Sci; 2012 Aug; 1266():7-17. PubMed ID: 22901251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The battlefield of pluripotency.
    Smith A
    Cell; 2005 Dec; 123(5):757-60. PubMed ID: 16325569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Driving pluripotency and reprogramming: nuclear receptors at the helm.
    Gonzales KA; Ng HH
    Semin Cell Dev Biol; 2013 Dec; 24(10-12):670-8. PubMed ID: 23916717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reprogramming cell fate to pluripotency: the decision-making signalling pathways.
    Sanges D; Cosma MP
    Int J Dev Biol; 2010; 54(11-12):1575-87. PubMed ID: 21305473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of epigenetic regulators and cell fate decisions by miRNAs.
    Gruber AJ; Zavolan M
    Epigenomics; 2013 Dec; 5(6):671-83. PubMed ID: 24283881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the phosphoinositide 3-kinase-dependent transcriptome in murine embryonic stem cells: identification of novel regulators of pluripotency.
    Storm MP; Kumpfmueller B; Thompson B; Kolde R; Vilo J; Hummel O; Schulz H; Welham MJ
    Stem Cells; 2009 Apr; 27(4):764-75. PubMed ID: 19350676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and biological properties of pluripotent embryonic stem cells.
    Ohtsuka S; Dalton S
    Gene Ther; 2008 Jan; 15(2):74-81. PubMed ID: 17989701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.